406 (PB394): Exploring peptide derived from Signaling Lymphocytic Activation Molecule-1 as a novel anti-cancer treatment for multiple myeloma
2024 · European Journal of Cancer · 0 citations
https://doi.org/10.1016/j.ejca.2024.114918
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
16
Citations
1
h-index
1
i10-index
Ingvild Bergdal Mestvedt is an academic researcher from Norwegian University of Science and Technology. The author has contributed to research in topics: Immune Response and Inflammation & Multiple Myeloma Research and Treatments & interferon and immune responses. The author has an h-index of 1, co-authored 6 publications.
ORCID: 0009-0008-5079-7501Click to start Chat